Article
Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients.
YRG Centre for AIDS Research and Education, VHS, Chennai, India.
AIDS (impact factor:
6.24).
04/2005;
19(6):625-7.
pp.625-7
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database.
[show abstract] [hide abstract]
ABSTRACT: To assess the risk and the prognostic significance of tuberculosis (TB) diagnosis in patients from The TREAT Asia HIV Observational Database, a multi-centre prospective cohort of HIV-infected patients receiving HIV care in the Asia-Pacific region. The risk of TB diagnosis after recruitment was assessed in patients with prospective follow-up. TB diagnosis was fitted as a time-dependent variable in assessing overall survival. At baseline, 22% of patients were diagnosed with TB. TB incidence was 1.98 per 100 person-years during follow up, with predictors including younger age, lower recent CD4 count, duration of antiretroviral treatment, and living in high TB burden countries. Among 3279 patients during 6968 person-years, 142 died (2.04 per 100 person-years). Compared to patients with CDC category A or B illness only, mortality was marginally higher in patients with single Non-TB AIDS defining illness (ADI), or TB only (adjusted HR 1.35, p = 0.173) and highest in patients with multiple non-TB AIDS or both TB and other ADI (adjusted HR 2.21, p < 0.001). The risk of TB diagnosis was associated with increasing immunodeficiency and partly reduced by antiretroviral treatment. The prognosis of developing TB appeared to be similar to that following a diagnosis of other non-TB ADI.BMC Infectious Diseases 05/2009; 9:46. · 3.12 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
generic non-nucleoside reverse transcriptase inhibitor-based regimens
initial results
median baseline plasma viral load
plasma viral load
tertiary HIV referral centre
YRG Centre